National Cancer Institute
Epidemiology and Genomics Research
March 2014

About Us

Funding Opportunity
NCI participating in US-South Africa Program for Collaborative Biomedical Research (U01)
Application due dates: April 22, 2014
Expires: April 23, 2014

Early-Stage Innovative Molecular Analysis Technology Development for Cancer Research (R21)
Application due dates: May 20, 2014; September 18, 2014
Expires: September 19, 2014

Validation and Advanced Development of Emerging Molecular Analysis Technologies for Cancer Research (R33)
Application due dates: May 20, 2014; September 18, 2014
Expires: September 19, 2014

Early-Stage Development of Innovative Technologies for Biospecimen Science (R21)
Application due dates: May 20, 2014; September 18, 2014
Expires: September 19, 2014

Validation and Advanced Development of Emerging Technologies for Biospecimen Science (R33)
Application due dates: May 20, 2014; September 18, 2014
Expires: September 19, 2014

Notice of Intent to Publish a Funding Opportunity Announcement for Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts (UM1)
Grants Policy AnnouncementsGrantsmanshipAnnouncements
NIH Fiscal Policy for Grant Awards - FY 2014

Changes to Public Access Policy Compliance Efforts Apply to All Awards with Anticipated Start Dates on or after July 1, 2013
Job OpportunitiesJobOpportunity
Program Director, Clinical and Translational Epidemiology Branch

Program Director, Host Susceptibility Factors Branch

Cancer Research Training Award Fellow, Modifiable Risk Factors Branch

Upcoming Seminars & WorkshopsEvents
Symposium on Advances in Endometrial Cancer Epidemiology and Biology
March 17-18, Harvard University in Boston, MA

American Epidemiological Society Annual Meeting
March 20-21, 2014 at Rutgers University in New Brunswick, NJ

Third Symposium on Translational Genomics
March 20-21, 2014 in Bethesda, MD

Symposium on Global Cancer Research
May 5, 2014 in Washington, DC

50th American Society of Clinical Oncology Annual Meeting
May 30-June 3, 2014 in Chicago, IL

Emerging Issues in Head and Neck Cancer Workshop
June 2-3, 2014 in San Pietro in Bevagna, Italy

InterLymph Annual Meeting
June 17-20, in Los Angeles, CA

North American Association of Central Cancer Registries Annual Conference
June 21-26, 2014 in Ottawa, Canada

International Association of Cancer Registries Annual Conference
June 25-28, 2014 in Ottawa, Canada

AACR Integrative Molecular Epidemiology Workshop
August 11-15, 2014 in Boston, MA

IEA World Congress of Epidemiology
August 17-21, 2014 in Anchorage, AK

International Genetic Epidemiology Society (IGES) Annual Meeting
August 28-30, 2014, in Vienna, Austria
Abstracts due: June 4, 2014

2014 Annual Meeting of the American College of Epidemiology
September 7-9, 2014 in Silver Spring, MD
Abstracts due: May 5, 2014
The Epidemiology and Genomics Research Program (EGRP), in the Division of Cancer Control and Population Sciences (DCCPS) funds research in human populations to understand the causes of cancer and related outcomes.

The Program fosters interdisciplinary collaborations, as well as the development and use of resources and technologies to advance cancer research and translation of this research, which serve as the basis for clinical and public health interventions.
Send Us Your IdeasSendUsYourIdeas
EGRP encourages readers to submit items of interest to Cancer Epidemiology Matters E-News.  EGRP reserves the right to decide whether or not materials are appropriate for inclusion.
Contact UsContactUs
Epidemiology and Genomics Research Program
Division of Cancer Control and Population Sciences
National Cancer Institute
9609 Medical Center Drive
4 East, MSC 9763
Bethesda, MD  20892
(240) 276-6730

For UPS, FedEx, and courier services, please use:
Rockville, MD  20850


8 Must-See Sessions for Epidemiologists at the 2014 AACR Annual MeetingAACR

In a few weeks, the 105th Annual Meeting of the American Association for Cancer Research (AACR) will begin in San Diego, California. To help you get the most out of this year's presentations, we've assembled a list of sessions presented by National Cancer Institute (NCI) staff to highlight important resources and topics in cancer epidemiology and genomics.

Sunday, April 6

Monday, April 7

Tuesday, April 8

Wednesday, April 9


For a list of all AACR Annual Meeting sessions presented by NCI and NIH (including several on funding opportunities and the grants review process) visit the AACR 2014 page on the NCI website.

What Is an NCI Program Director and How Can They Help You?ProgramDirector  

The Epidemiology and Genomics Research Program (EGRP) in the Division of Cancer Control and Population Sciences (DCCPS) is served by more than 20 Program Directors (PDs) who support both external investigators and the scientific priorities of the NCI.

EGRP PDs have scientific expertise in a variety of fields, including genetics, epigenetics, nutrition, pharmacoepidemiology, and cohort and consortia development. They administer scientific programs, oversee portfolios of funded research projects led by investigators at research institutions across the U.S. and internationally, act on priorities for cancer epidemiology research, and advocate for various scientific areas.

PDs are responsible for identifying research gaps and developing concepts for new NCI and trans-NIH funding opportunities. They stay abreast of scientific advances by attending scientific lectures and national conferences, discussing science with grant applicants and grantees, reading the scientific literature, and participating in various seminars, workshops, and conferences. They use this knowledge of research opportunities and gaps to identify potential collaborations, needs for infrastructure, and special initiatives that researchers can take advantage of to move the science forward.

In addition, NIH requires that Program staff maintain an up-to-date knowledge of NCI and NIH administrative policies and procedures related to research administration. Lastly, PDs serve as NCI liaisons to external organizations and committees.

PDs play a dual role, serving as the investigators' advocates to the NCI/NIH and as representatives of NCI to the investigators. These interactions span the life cycle of the grant. EGRP PDs serve investigators in the cancer research community by helping them identify funding opportunities pertinent to their research interests; explaining differences between various NIH grant mechanisms; discussing with investigators how their research interests fit within the strategic priorities of EGRP, DCCPS, and the NCI; and helping investigators understand NCI and NIH pre-submission policies and procedures, such as large grants (>$500,000), amended applications, competing continuations, and receipt dates.

PDs monitor grantees' progress and compliance with NIH funding policies during the life of the grant and are the initial point of contact when questions arise about the management of the study; a request is submitted to modify the study (i.e., changes to key personnel, budget, specific aims, grantee institution); or there is an anticipated carryover or no-cost extension.

Investigators who have questions about their research ideas, grant mechanisms, or NCI/NIH policies that cannot be answered by information available on NCI and NIH web pages are welcome to contact EGRP PDs for assistance. Those who do not already have an assigned PD are invited to review the EGRP staff list to identify PDs with related scientific interests.

Other resources:  

This email was sent to by 

Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute | 9609 Medical Center Drive | 4 East, MSC 9763 | Bethesda | MD 20892

Contact Us | Privacy Policy | Accessibility | FOIA

 U.S. Department of Health and Human Services
National Institutes of Health | National Cancer Institute |